Krüger et al. demonstrated that the loss of endothelial FTO protected patients from obesity-induced insulin resistance, hyperglycemia, and hypertension in the presence of adipose tissue inflammation and obesity. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.